TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 5 | -4 | 4 | 34 | 27 | 122 | 31 |
| P | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 | |||
| S | %ret | 1 | 1 | 1 | 3 | -3 | -18 | -41 | -33 | -36 | -21 |
| S | %wins | 0 | 100 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/15 20:30 | 8/18/15 | TBPH | Theravance Biopharma, Inc. | E9 | Health | Drug | Pharmaceutical Preparations | Lee Junning | CA | O | SVP,Tech | P | 116 | 12.90 | 2 | 9 | 5 | 179 | I | -56 | -39 | -16 | -4 | 0 | 1 | -1 | 5 | -4 | 4 | 34 | 27 | 122 | |
8/15/14 19:00 | 8/13/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Lee Junning | CA | O | SVP,Tech | M.d | 926 | 12.44 | 23 | 74 | 39 | 265 | D | 9 | -24 | -27 | -1 | -25 | -1 | 3 | 3 | 3 | -3 | -18 | -41 | -33 | -36 |
8/15/14 19:00 | 8/13/14 | THRX | Theravance Inc | DE | Health | Drug | Pharmaceutical Preparations | Lee Junning | CA | O | SVP,Tech | S.d | -1,202 | 22.50 | 23 | -53 | -17 | 265 | D | 9 | -24 | -27 | -1 | -25 | -1 | 3 | 3 | 3 | -3 | -18 | -41 | -33 | -36 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |